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Recombinant human acetylcholinesterase (HuAChE) and selected mutants (E202Q, Y337A, F,450A) were studied with respect to catalytic activity 
towards charged and noncharged substrates, phosphylation with organophosphorus (OP) inhibitors and subsequent aging of the OP-conjugates. 
Amino acid E450, unlike residues E202 and Y337, is not within interaction distance from the active center. Yet, the bimolecular rates of catalysis 
and phosphylation are 30~100 fold lower for both FA50A and E202Q compared toY337A or the wild type and in both mutants the resulting 
OP-conjugates show striking resistance toaging. It is proposed that a hydrogen bond network, that maintains the functional rchitecture of the 
active center, involving water molecules and residues E202 and E450, is responsible for the observed behaviour. 
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1, INTRODUCTION 
Cholinesterases (ChE's) are readily phosphylated**, 
at the active site serine, by a variety of organo- 
phosphonates and organophosphates (OP) [1,2]. The 
OP-ChE conjugates then undergo postinhibitory proc- 
esses, the nature and extent of which depend upon the 
structure of the inhibitor and the particular enzyme 
studied. Spontaneous reactivation, through displace- 
ment of the phosphyl moiety (Scheme 1) from the active 
site, is usually very slow [3]; however, the enzyme can 
be reactivated by various oxime nucleophiles ('Re' in 
Scheme 1) [1,4], In certain cases such reactivation is 
thwarted due to a concomitant unimolecular process 
termed aging [1,5]. It was proposed that this process 
consists of dealkylation through alkyl-oxygen bond 
scission resulting in a formal negative charge in the 
OP-ChE conjugate (see Scheme 1) [6,7]. The aged OP- 
conjugate is refractive to reactivation [6,8] and thus 
renders treatment, following intoxication with certain 
OP insecticides or nerve gas agents, extremely difficult 
[9]. 
*Corresponding author. Fax: (972) (8) 401 404. 
** The comprehensive term 'phosphyl' isadopted from Bourne and 
Williams [37] for all tetravalent P electrophilic groups. 
Although the aging process is understood on the basis 
of a carbonium ion mechanism [10] and depends on the 
phosphorus tereochemistry in the conjugates [11], the 
role of the enzyme nvironment in facilitating the proc- 
ess is not well understood. In general, the catalysis of 
aging is particularly efficient in ChE's compared to OP- 
conjugates with other serine hydrolases [12,13], indicat- 
ing a specific involvement of residues vicinal to the 
phosphyl moiety in the ChE active center. 
Recently we have generated a large number of recom- 
binant human acetylcholinesterase (HuAChE) mutants 
and identified amino acids important for maintaining 
the structural integrity of the enzyme [14,15] as well as 
residues involved in catalysis and in interactions with 
various substrates and reversible inhibitors [16-18]. In 
these studies, active center esidues comprising the cata- 
lytic triad, the anionic subsite and the acyl pocket, as 
well as residues of the peripheral anionic subsites were 
identified. Here we report on the extension of this ap- 
proach to gain insight into reactions with irreversible 
OP inhibitors and the subsequent postinhibitory proc- 
esses. 
Comparison of reaction rates of inhibition and aging 
of selected active center HuAChE mutants and the wild 
type enzyme reveals key residues involved in the gener- 
ation and stabilization of the negatively charged 
E-P-O-  conjugate. 
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2. MATERIALS AND METHODS 
2.1. Substrates and inhibitors 
Acetylthiocholine iodide (ATC), 5,5'-dithiobis(2-nitrobenzoic acid) 
(DTNB), diisopropyl phosphorofluoridate (DFP) were purchased 
from Sigma. S-3,3-dimethylbutyl thioacetate (CH3C(O)SC 2- 
H4C(CH3)3-TB) was synthesized and purified as described previously 
[18]. Purified pinacolyl methylphosphonofluoridate (soman) was a gift 
from Dr. Y. Segall; 7-(methylethoxyphosphophinylloxy)-l-methylqui- 
nolinium iodide (MEPQ) a gift from Dr. Y. Ashani; and l-(2-hy- 
droxyiminomet hylpyridinium)- 1 -(4-carboxyiminopyridinium)dimeth- 
ylether dichloride (HI-6) was a gift from Dr. G. Amitai. 
2.2. Recombinant HuA ChE and its mutants 
Expression of recombinant HuAChE and its mutants in a human 
embryonal kidney derived 293 cell line, was described previously 
[15,19,20]. Generation of mutants E202Q(E199)* and Y337A(F330) 
was described previously [18]. Substitution of residue E450(E443) was 
carried out by replacement of the BstBI-BamHI DNA fragment of the 
AChE-w3 variant [15] with synthetic DNA duplexes carrying the 
GCC(Ala) codon. Stable recombinant cell clones expressing high lev- 
els of each of the mutants were established according to the procedure 
described previously [20]. The resulting recombinant clones were 
propagated in multitray systems [21 ]. The secreted enzymes in the cell 
supernatant (2-6 liters) were purified (over 90% purity) by affinity 
chromatography asdescribed previously [20]. 
2.3. Kinetic studies and analysis of data 
AChE activity was assayed according to Ellman et al. [22] (in the 
presence of 0.! mg/ml BSA, 0.3 mM DTNB, 50 mM sodium phos- 
phate buffer pH 8.0), carried out at 27°C and monitored by a Thermo- 
max microplate reader (Molecular Devices). Michaelis-Menten con- 
stant (Kin) values were obtained from the double-reciprocal Line- 
weaver-Burk plots and kca~ calculations were based on ELISA quan- 
titations [17] as well as on determination of active site concentration 
by MEPQ titrations [14,23] (see Fig. 2). Phosphylation experiments 
were carried out using at least 4 different concentrations of OP-inhib- 
itor (I) and two concentrations of enzyme, and enzyme residual activ- 
ity (E) at various times was monitored. The apparent bimolecular 
phosphylation rate constants (k~ in Scheme 1) determined under 
pseudo-first-order conditions were computed from the plot of slopes 
of ln(E) vs. time at different inhibitor concentrations. Rate constants 
under second-order conditions were determined from plots of ln{E/ 
[Io - (Eo E)]} vs. time. In aging experiments he initial OP-conju- 
gates were obtained under conditions where ki[Io] >> k, (see Scheme 1) 
and with over 98% inhibition of the initial enzyme activity. The reac- 
tivatable (non-aged OP-conjugate) fraction was determined by reacti- 
vation with HI-6 under conditions where kr[Re] > k, (Scheme 1). The 
excess OP-inhibitor was removed either by column filtration (Se- 
phadex G 15) or by 100-fold ilution, prior to reactivation. The activity 
of the reactivated enzyme (Er) was routinely corrected for the inhib- 
itory effect of the reactivator [24]. The first-order ate constants of 
aging, ka, were determined from the slopes of ln(Er) vs. time. 
3. RESULTS 
3.1. Selection of OP inhibitors and HuA ChE mutants for 
study 
The OP inhibitors chosen for this study represent two 
important classes of extensively studied agents [3]: diiso- 
propyl phosphorofluoridate (DFP) and pinacolyl meth- 
ylphosphonofluoridate (soman). Both of these OP in- 
hibitors result in OP-ChE conjugates that undergo 
aging [1]. For the selection of mutants we were guided 
by molecular models of OP-HuAChE adducts [25], 
based on the X-ray structure of TcAChE [26] and on 
structures of OP-conjugates of chymotrypsin [27]. Ini- 
tially, residues Y337 and E202 were selected since the 
main focus of this study is the evaluation of interactions 
of the active center residues with the initial phosphyl 
moiety and in particular with the alkyl leaving group 
and the resulting P-O- moiety in the aged conjugate 
I %,/0 
R 
* Amino acids and numbers in parentheses refer to the position of 
analogous residues in Torpedo AChE (TcAChE) according to the 
recommended nomenclature [38]. 
Fig. 1. Schematic presentation of the OP HuAChE conjugate. Resi- 
due domains within interaction distances [25] from the phosphorus 
substituents are displayed, as well as the catalytic site serine 203. 
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(Fig. 1). The models suggest that amino acid Y337 is 
vicinal to the isopropyl (DFP) or the pinacolyl (soman) 
groups of the phosphyl moieties of the corresponding 
OP-HuAChE conjugates and residue E202 is proximal 
to the scissible O-alkyl bond. Indeed, Qian and Kovach 
[28] proposed recently that E202 may be involved in 
stabilization of the evolving carbonium ion during the 
dealkylation process. In addition to mutation in these 
two residues, we included in the study HuAChE mu- 
tated at position 450. Residue E450, is remote from the 
phosphyl moiety but may affect he positioning of E202 
in the active center (see Fig. 3 and discussion). 
3.2. Effect of mutation on hydrolysis of charged and un- 
charged substrates 
The three HuAChE mutants Y337A, E202Q and 
E450A were compared with respect o their efficiency 
in catalyzing the hydrolysis of acetylthiocholine (ATC) 
and its uncharged isoester S-3,3-dimethylbutyl thioace- 
tate (TB). As shown previously [18], replacement of the 
aromatic residue Y337 had only a marginal effect on the 
kinetic parameters (Km and k~at) for the two substrates 
(Table I) while the corresponding values for hydrolysis 
of ATC catalyzed by E202Q HuAChE [16], or of the 
corresponding mutation E199Q in TcAChE [29], differ 
significantly from those of the wild type enzyme. We 
now demonstrate hat this decrease in catalytic effi- 
ciency of E202Q is observed also for the noncharged 
substrate TB (Table I), This indicates that the effect of 
replacement of E202 of HuAChE on catalysis is not 
solely due to electrostatic nteractions with the sub- 
strate. Interestingly, a similar pattern of reduction of the 
catalytic parameters, for both ATC and TB, is observed 
when residue E450, which is remote from the active site, 
is replaced by alanine (Table I). 
3.3. Interaction of HuAChE mutants with irreversible 
OP inhibitors 
To determine the effects of mutations on the stoi- 
chiometry of the inhibition reaction of the various 
AChEs by the OP inhibitors the recombinant enzymes 
were titrated with different concentrations of soman 
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Fig. 2. Active site titration of HuAChE and its mutants with soman 
and MEPQ. In all titration experiments the concentration f the cata- 
lytic subunits of HuAChE and its mutants was approximately 0.12 
¢tg/ml as determined by ELISA. The residual activity was determined 
after 30 and 60 rain incubation (27°C) with soman (WT (m), Y337A 
(o), E202Q (A) and E450A (+)) and MEPQ (WT (~), Y337A (©), 
E202Q (zx) and E450A (x)). The intercepts for zero activity were deter- 
mined by extrapolation and the values of active site concentration 
were approximately 2,05 x 10 -~2 mol/ml for MEPQ and twice as high 
for soman titration (see text). 
OP-inhibitor of AChEs, commonly used as titrant for 
standardization f concentration of AChE active sites 
[23]. As shown in Fig. 2, the wild type enzyme and all 
the mutants examined show the expected 1: t stoichiom- 
etry in reactions with MEPQ. The concentrations of the 
active site subunits, determined by this method, are in 
good agreement (+ 10%) with results obtained from the 
quantitative immunological (ELISA) assays. Further- 
more, under similar experimental conditions, the titra- 
tion studies demonstrate that for soman 1:2 stoichiom- 
etry is obtained for the wild type enzyme as well as for 
the mutants examined. Due to the chirality of the phos- 
phorous in soman, this OP-inhibitor is known to exhibit 
a marked stereoselectivity in reactions with AChE from 
Table I 
Compilation of kinetic constants for ATC and TB hydrolysis by HuAChE and its mutants 
ATC TB 
HuAChEs K,, k~a , k.~,p K m 
(raM) (× 10 -s min -I) (× 10 -8 M -1 min -1) (mM) (× 10 -5 min -~) (x 10 -s M -~ rain -l) 
Wild type 0.13 + 0.015 3.7 ± 0.3 28.5 0.28 ± 0.08 
Y337A 0.10 ± 0.01 1.0 ± 0.1 10.0 0.20 + 0.03 
E202Q 0.35 + 0,04 0.75 +_ 0.15 2.1 0.23 + 0.03 
E450A 0.35 +_ 0.04 0.10 ± 0.02 0.3 0.20 +_ 0,04 
0.5 _+ 0.1 1,8 
0.2 + 0.05 1.0 
0.1 + 0.04 0,43 
0.006 + 0.001 0,03 
"The apparent bimolecular rate c o n s t a n t  (kapp) was calculated from the ratio of kcat]K m. 
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various sources [30], including recombinant HuAChE 
[14]. Thus, the HuAChE mutants tudied appear to re- 
tain the stereoselectivity towards oman diastereomers. 
The actual bimolecular reaction rates of phosphyla- 
tion of HuAChE and its mutants, by DFP and soman, 
were determined under either pseudo-first-order or sec- 
ond-order conditions (Table II). For the wild type en- 
zyme the rates obtained for DFP and soman are in 
agreement with values published previously for differ- 
ent AChEs [31-33]. It appears that replacement ofY337 
by alanine had a minimal effect on the bimolecular rate 
constants of inhibition. On the other hand, replacement 
of E202 by glutamine resulted in a marked decrease of 
the phosphylation rates. Radic et al. have recently re- 
ported similar effects for the reactivity of an analogous 
mutant of TcAChE (E199Q) with DFP [29]. Again, as 
for the acylation process, we find that the effect of re- 
placement of E450 on the rates of phosphylation (Table 
II), parallels that of E202 substitution. It is worth noting 
that despite the marked decrease in the rates of 
phosphylation of the HuAChE E202Q and E450A mu- 
tants, the relative reactivity of DFP and soman with 
each mutant resembles that observed for the wild type 
enzyme. 
Examination of the process of aging through meas- 
urements of the residual reactivatable enzyme activity 
[24] was carried out with the potent oxime reactivator 
HI-6 [34]. Under the experimental conditions used, we 
were able to achieve substantial regeneration of enzy- 
matic activity, even for the pinacolyl methylphosphonyl 
derivative of the wild type HuAChE which proceeds 
Table II 
Rate constants of phosphylation (k0 and aging (k~) of HuAChE and 
its mutants 
k i ka 
(x 10 -4 M ~ • rain -~) (x 103 rain-i) 
HuAChEs DFW soman b soman ~ 
Wild type 9.6 + 0.52 8600 _+ 1970 91 + 12 
(1.o) (1.o) (1.o) 
Y337A 3.1 + 0.15 2950 _+ 636 180 + 64 
(0.32) (0.34) (2.0) 
E202Q 0.18 _+ 0.06 312 + 100 0.58 + 0.06 
(0.019) (0.036) (0.0064) 
E450A 0.085 + 0.03 120 _+ 20 3.4 + 0.18 
(0.009) (0.014) (0.037) 
The correlation coefficients of the corresponding linear plots were at 
least 0.95. Values represent mean of at least 3 independent experi- 
ments. Numbers in parentheses represent the values relative to the wild 
type. 
a Concentration range of DFP: for wild type and Y337A 5 x 10 -7. 
3 x 10 -6 M and for E202Q and E450A 5 x 10 -6- 7.5 x 10 -5 M. 
b Concentration range of soman: for wild type and Y337A 4 x 10 -~°- 
1.4 x I0 -8 M and for E202Q and E450A 1.4 x 10-8-2.8 x 10 .7 M. 
c All enzymes were 95-98% inhibited by soman and reactivated at 
various times by HI-6 (1-5 x l0 -4 M), 
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Fig. 3. Involvement of residues E202 and E450 in the hydrogen bond 
network across the active center of HuAChE. The positions of water 
molecules in the model of the HuAChE are assumed to be equivalent 
to those in the X-ray structure of TcAChE [26]. Segments of the two 
backbone stretches, panned by the H-bond network, are displayed. 
The separation of the two backbone segments determines the relative 
orientation of the oxyanion hole (GI 21, G 122) and the catalytic triad 
(H447), The distances within the network, marked by broken lines, are 
as follows: N(G121)~O(HzO) 2.58 ~; O(Y133)-O(H20) 2.50 ~; 
O(E202)-O(H20 ) 3.01/~.; O(E450)-O(H20) 2.80/~; O(E202)-O(H20) 
2.36 A; N(G441)-O(H20) 3.07/k. 
very rapidly towards the non-reactivatable (aged) en- 
zyme. It appears that reactivation of OP conjugates with 
the wild type HuAChE and Y337A enzymes proceeds 
at comparable rates while for the E202Q and E450A 
mutants, reactivation is slower (data not shown). 
The first-order ate constant for aging of the diiso- 
propyl phosphoryl derivative of HuAChE was deter- 
mined to be 3.5 x 10 .4 min -1. This value is 260-fold 
lower than that for the corresponding pinacolyl meth- 
ylphosphonyl derivative (Table II), and in good agree- 
ment with values published for the same OP-conjugates 
in other AChEs [24,32]. For the diisopropyl phosphoryl 
derivatives of E202Q and E450A HuAChE's the rates 
of aging appear to be very slow and not measurable 
under the experimental conditions used. Consequently, 
there is no experimental evidence that the aging process 
occurs in these cases. For the pinacolyl meth- 
ylphosphonyl derivative of the Y337A, the first-order 
rate constant for aging is similar to that of the wild type 
enzyme while the corresponding values for E202Q and 
E450A are 150- and 30-fold lower, respectively. If we 
assume a similar decrease in the rate of aging for the 
diisopropyl phosphoryl derivatives of E202Q and 
E450A, then we could expect half-lives of 83 and 17 
days, respectively, for these processes. It is therefore not 
surprising that no aging could be observed with DFP- 
conjugates of these mutants. 
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4. DISCUSSION 
Molecular modeling studies of HuAChE and its 
phosphonylated conjugates implicated several residues, 
at the active center, in stabilizing the initial OP conju- 
gate (Fig. 1) and in facilitating the subsequent aging 
process. These residues include the catalytic triad ($203, 
H447 and E334), the putative oxyanion hole (GI21, 
G122 and A204), the pockets accommodating the 
alkoxy groups (W86, Y337 and F338), and residues 
which constitute the acyl pocket for ACh (F295 and 
F297) as well as E202 which is proximal to the P -O-C  
linkage. The participation of most of these residues in 
the analogous process of acylation was recently demon- 
strated experimentally, by site directed mutagenesis [15- 
17,29,35]. The kinetic studies reported here suggest hat 
in phosphylation and even in the dealkylation of the OP 
conjugates of HuAChE, residue Y337 appears to have 
a minimal contribution. On the other hand replacement 
of E202 by a neutral residue results in 30 150-fold re- 
duction in the bimolecular rate constant of phosphyla- 
tion and in the first-order ate constant of aging. 
Based on modeling studies of the soman-TcAChE 
adduct it was proposed by Qian and Kovach that the 
carboxylate of E199 (equivalent to E202 in HuAChE) 
would be within interaction distance of the positive 
charge on the chiral carbon, thereby facilitating the de- 
tachment of the alkyl group by means of electrostatic 
interactions [28]. However, it should be emphasized that 
substitution of E202 by glutamine has pleiotropic ef- 
fects of comparable magnitude on catalytic activity to- 
wards both charged and non-charged substrates (Table 
I), on substrate inhibition [16,29], on interactions with 
reversible inhibitors [17,29] as well as on the rates of 
phosphylation by DFP and soman (Table II). These 
observations are therefore consistent with our previous 
suggestion [16,17] that replacement of E202 probably 
disrupts the overall spacial organization of the active 
center. Nevertheless this conformational change is not 
sufficient o abolish the stereoselectivity of the E202Q 
mutant for the soman diastereomers (Fig. 2). 
Some clues as to how residue E202 could play such 
a role in maintaining the architecture of the active cen- 
ter is provided by the studies by Sussman et al. [26] on 
the X-ray structure of TcAChE. As shown in Fig. 3, the 
carboxyl group of E202 is a central element in a network 
of hydrogen bonds that spans the cross-section of the 
active center gorge. This array bridges two AChE back- 
bone segments one of which contains the residues con- 
stituting the oxyanion hole while the other includes the 
catalytic triad histidine (H447). In this array, residue 
E202 is bound, via a water molecule, to residue E450. 
Therefore, although E450 is quite remote from the ac- 
tive site (distances of O)'-$203 from C8 of E202 and 
E450 are 5.29/k and 9.72/k, respectively), it is expected 
that substitution of E450 by alanine would be as disrup- 
tive to the hydrogen bond network as is the replacement 
of E202 by the neutral residue glutamine. In accordance 
with this prediction, the E450A HuAChE mutant exhib- 
ited reduced reactivity towards the substrates ATC and 
TB, or towards the OP inhibitors DFP and soman, in 
a similar manner to that observed for the mutant 
E202Q. Furthermore the OP conjugates of both E202Q 
and E450A mutants exhibit marked resistance to aging. 
A common mechanistic element, in these diverse proc- 
esses, is a protonation step. This protonation can be 
mediated by the imidazole moiety of the catalytic triad 
histidine-447, and it is reasonable to assume that the 
appropriate positioning of H447 is achieved (Fig. 3) via 
the hydrogen bond network involving E202-water- 
E450 alignment in the active center. 
Finally in addition to understanding some of the 
basic aspects of the mechanism of catalysis, phosphyla- 
tion and aging, the findings reported here may have 
practical implications. Since aging is an irreversible 
process leading to a nonreactivatable enzyme, the dem- 
onstrated ability to engineer ChEs resistant o aging 
should be advantageous with respect o the proposed 
utility of such biomolecules for treatment [36] against 
OP insecticide poisoning or decontamination of envi- 
ronmentally harmful OP agents. 
Acknowledgements: We thank, Tamar Sery, Nehama Zeliger and Lea 
Silberstein for their excellent technical ssistance; Dr. Y. Ashani for 
fruitful discussions and Dr. I.M. Kovach for sharing information 
prior to publication. Gifts of reagents from Drs. G. Amitai, Y. Ashani, 
and Y. Segall are greatly appreciated. This work was supported by the 
U.S. Army Research and Development Command, Contract 
DAMD17-93-C-3042 (to A.S.). 
REFERENCES 
[1] Aldrich, W.N. and Reiner, E. (1972) Enzyme Inhibitors as Sub- 
strates, Elsevier, Amsterdam. 
[2] Taylor, P. (1990) in: The Pharmacological B sis of Therapeutics, 
8th edn (Gilman, A.G., Goodman, L.S., Rall, T.W. and Murad, 
F. eds.) pp. 131-149, Macmillan Press, New York. 
[3] Main, A.R. (1976) in: Biology of Cholinergic Function (Gold- 
berg, A.M. and Hanin, I. eds.) pp. 269-353, Random Press, New 
York. 
[4] Froede, H.C. and Wilson, I.B. (1971) in: The Enzymes, vol. 5, 3rd 
edn. (Boyer, P.D. ed.) pp. 87-114, Academic Press, Orlando, FL. 
[5] Hobbiger, F. (1955) Brit. J. Pharmacol. 10, 356-359. 
[6] Michel, H.O., Hackley Jr, B.E., Berkowitz, L., List, G., Hackley, 
E.B., Gilliam, W. and Paukan, M. (1967) Arch. Biochem. Bio- 
phys. 121, 29 34. 
[7] Berman, H.A. and Decker, M.M. (1986) Biochim. Biophys. Acta 
872, 125-133. 
[8] Gray, A.E (1984) Drug Metabolism Rev. 15, 557 589. 
[9] Glickman, A.H., Wing, K.D. and Casida, J.E. (1984) Toxicol. 
Appl. Pharmacol. 73, 16-22. 
[10] Benschop, H.P. and Keijer, J.H. (1966) Biochim. Biophys. Acta 
128, 586-588. 
[11] Berman, H.A. and Decker, M.M. (1989) J. Biol. Chem. 264, 
3951-3956. 
[12] Van der Drift, A.C.M., Beck, H.C., Decker, A.G., Hulst, A.G. 
and Wils, E.R.G. (1985) Biochemistry 24, 6894-6903. 
[13] Grunwald, J., Segal, Y., Shirin, E., Waysbort, D., Steinberg, N., 
Silman, I. and Ashani, Y. (1989) Biochem. Pharmacol. 38, 3157- 
3168. 
219 
Volume 334, number 2 FEBS LETTERS November 1993 
[14] Velan, B., Grosfeld, H., Kronman, C, Leitner, M., Gozes, Y., 
Lazar, A., Flashner, Y., Markus, D., Cohen, S. and Shafferman, 
A. (1991) J. Biol. Chem. 266, 2397%23984. 
[15] Shafferman, A., Kronman, C., Flashner, Y., Leitner, M., 
Grosfeld, H., Ordentlich, A., Gozes, Y., Cohen, S., Ariel, N., 
Barak, D., Harel, M., Silman, I., Sussman, J.L. and Velan, B. 
(1992) J. Biol. Chem. 267, 17649-17648. 
[16] Shafferman, A., Velan, B., Ordentlich, A., Kronman, C., 
Grosfeld, H., Leitner, M., Flashner, Y., Cohen, S., Barak, D. and 
Ariel, N. (1992) in: Multidisciplinary Approaches to Cholinest- 
erase Functions (Shafferman A. and Velan B. eds) pp. 165-175, 
Plenum Press, New York. 
[17] Shafferman, A., Velan, B., Ordentlich, A., Kronman, C., 
Grosfeld, H., Leitner, M., Flashner, Y., Cohen, S., Barak, D. and 
Ariel, N. (1992) EMBO J. 11, 3561-3568. 
[18] Ordentlich, A., Barak, D., Kroman, C., Flashner, Y., Leitner, 
M., Segall, Y., Ariel, N., Cohen, S., Velan, B. and Shafferman, 
A. (1993) J. Biol. Chem. 268, 17083-17095. 
[19] Velan, B., Kronman, C., Grosfeld, H., Leitner, M., Gozes, Y., 
Flashner, Y., Sery, T., Cohen, S., Benaziz, R., Seidman, S., Shaf- 
ferman, A. and Soreq, H. (t991) Cell. Mol. Neurobiol. 11, 143- 
156. 
[20] Kronman, C., Velan, B., Gozes, Y., Leitner, M., Flashner, Y., 
Lazar, A., Marcus, D., Sery, T., Papier, A., Grosfeld, H., Cohen, 
S. and Shafferman, A. (1992) Gene 121,295 304. 
[21] Lazar, A., Reuveny, S., Kronman, C., Velan, B. and Shafferman, 
A. (1993) Cytotechnology (in press). 
[22] Ellman, G.L., Courtney, K.D., Andres, V. and Featherstone, 
R.M. (1961) Biochem. Pharmacol. 7, 8805. 
[23] Levy, D. and Ashani, Y. (1986) Biochem. Pharmacol. 35, 1079- 
1085. 
[24] De Jong, L.EA. and Kossen, S.P. (1985) Biochim. Biophys. Acta 
830, 345-348. 
[25] Barak, D., Ariel, N., Velan, B. and Shafferman, A. (1992) in: 
Multidisciplinary Approaches to Cholinesterase Functions (Shaf- 
tbrman A. and Velan B. eds.) pp. 195-199, Plenum Press, New 
York. 
[26] Sussman, J.L., Harel, M., Frolow, F., Oefner, C., Goldman, A., 
Toker, L. and Silman, I. (1991) Science 253, 872-879. 
[27] Harel, M., Su, C.T., Frolow, F., Ashani, Y., Silman, I. and 
Sussman, J.L. (1991) J. Mol. Biol. 221,909-918. 
[28] Qian, N. and Kovach, I.M. (1993) in: Proceedings of Medical 
Defense Bioscience Review (in press). 
[29] Radic, Z., Gibney, G., Kawamoto, S., MacPhee-Quigley, K., 
Bongiorno, C. and Taylor, E (1992) Biochemistry 3l, 9760-9767. 
[30] Benschop, H.E and De Jong, LEA. (1988) Acc. Chem. Res. 21, 
368-374. 
[31] Gray, EJ. and Dawson, R.M. (1987) Toxicol. Appl. Pharmacol. 
91, 140-144. 
[32] Benschop, H.R, Konings, C.A.G., Van Genderen, J. and De 
Jong, L.RA. (1984) Toxicol. Appl. Pharmacol. 72, 61 74. 
[33] Anderson, R.A., Aaroas, J., Gaare, G. and Fonnum, F. (1977) 
Gem Pharmacol. 8, 331-334. 
[34] Roussaux, C.G. and Dua, A.K. (1989) Can. J. Physiol. Pharma- 
col. 67, 1183-1189. 
[35] Vellom, D.C., Radic, Z., Li, Y., Pickering, N.A., Camp, S. and 
Taylor, R (1993) Biochemistry 32, 12-17. 
[36] Dunn, M.A. and Sidell, F.R. (1989) J. Am. Med. Ass. 262, 649- 
652. 
[37] Bourne, N. and Williams, A. (1984) J. Am. Chem. Soc. 106, 
7591-7596. 
[38] Massoulie, J., Sussman, J.L., Doctor, B.R, Soreq, H., Velan, B., 
Cygler, M., Rotundo, R., Shafferman, A., Silman, I. and Taylor, 
R (1992) in: Multidisciplinary Approaches to Cholinesterase 
Functions (Shafferman A. and Velan B. eds.) pp. 285-288, Ple- 
num Press, New York. 
220 
